濮阳东方医院口碑好收费低濮阳东方医院看妇科技术很专业,濮阳东方妇科医院很好,濮阳东方看男科收费低吗,濮阳东方看妇科技术值得信赖,濮阳东方评价如何,濮阳东方医院男科看阳痿收费不高,濮阳东方评价好不好

WASHINGTON, May 20 (Xinhua) -- The U.S. Food and Drug Administration (FDA) on Friday approved Sutent to treat patients with progressive neuroendocrine cancerous tumors located in the pancreas that cannot be removed by surgery or that have spread to other parts of the body.Neuroendocrine tumors found in the pancreas are slow-growing and rare. It is estimated that there are fewer than 1,000 new cases in the United States each year.This is the second new approval by the FDA to treat patients with this disease. On May 5, the agency approved Afinitor."FDA believes it is important to provide cancer patients with as many treatment options as possible," said Richard Pazdur, director of the Office of Oncology Drug Products in the FDA's Center for Drug Evaluation and Research. "The agency is committed to working with companies to bring innovative new therapies to the market and encourages companies to continue exploring additional uses for approved products."The safety and effectiveness of Sutent was established in a single study of 171 patients with metastatic (late-stage) or locally advanced (disease that could not be removed with surgery) disease who received Sutent or a placebo (sugar pill). The study was designed to measure the length of time a patient lived before their disease spread or worsened (progression-free survival).Results from the study demonstrate that Sutent provided benefit to patients by prolonging the median length of time they lived without the cancer spreading or worsening to 10.2 months compared to 5.4 months for patients who received placebo.In patients treated with Sutent for neuroendocrine pancreatic tumors, the most commonly reported side effects included diarrhea, nausea, vomiting, fatigue, anorexia, high blood pressure, energy loss, stomach pain, changes in hair color, inflammation of the mouth, and a decrease in infection-fighting white blood cells.Sutent is marketed by New York City-based Pfizer.

BEIJING, March 21 (Xinhua) -- Renowned Chinese liquor producer Kweichow Moutai Co., Ltd. announced Monday its annual net profit in 2010 rose 17.13 percent year on year on strong market demand.Its net profit hit 5.05 billion yuan (769.17 million U.S. dollars), the Guizhou-based firm said in its 2010 annual report filed to Shanghai Stock Exchange.The company's annual business revenue increased 20.3 percent from one year earlier to 11.63 billion yuan while earnings per share stood at 5.35 yuan.The economic rebound accelerated the development of liquor industry despite rising raw material prices, said the report.The A-share price of the upmarket distiller opened down 0.70 percent from the previous close to 189.8 yuan Monday.

HOUSTON, May 2 (Xinhua) -- The Offshore Techonology Conference, one of the world's largest offshore technology shows, kicked off here Monday.The five-day event, which attracted an estimated 72,000 victors from all around the world, not only provided a platform for the about 2,400 participating companies from 40 countries to lure visitors with their newest products and technologies, but also for the them to share insights and discuss issues the industry is facing.On Monday, a number of companies, including Halliburton and Baker Hughes, received the Spotlight on New Technology Award by the OTC for their new products and solutions.Founded in 1969, the annual Offshore Technology Conference is the world's foremost event for the development of offshore resources in the fields of drilling, exploration, production, and environmental protection. OTC is held annually at Reliant Center in Houston.

CANBERRA, March 23 (Xinhua) -- Up to 45 native species in Western Australia's Kimberley region will die out within 20 years if no action is taken, latest study showed on Wednesday.The Priority Threat Management to Protect Kimberley Wildlife report, released by Commonwealth Scientific and Industrial Research Organization (CSIRO) on Wednesday, was commissioned by the Wilderness Society.The report showed that at present, 20.2 million U.S. dollars a year is spent on conservation efforts in the Kimberley, which is home to an assortment of threatened species.However, the report said even if that money was spent properly, the region would still lose some 31 native animals.The numbers of many more birds, reptiles and mammals, such as the Spotted Tree Monitor and the Western Chestnut Mouse, would dwindle.It called for an immediate cash injection of 96 million U.S. dollars to save creatures like the Golden Bandicoot, the Scaly- Tailed Possum and the Monjon Rock Wallaby from extinction.It will follow by an ongoing investment of 40.43 million U.S. dollars annually in the Kimberley to protect its species, as well as boost plant life, help the climate and conserve indigenous land."This investment is great value," one of the report's six co- authors Hugh Possingham said in a statement released on Wednesday."We can save some of Australia's most iconic mammals and birds at a cost of only about one million U.S. dollars per species per year."

MADRID, Jan. 24 (Xinhua) -- The Spanish branch of Industrial and Commerce Bank of China (ICBC) was officially inaugurated in Madrid Monday.ICBC President Jiang Jianqing, Spanish Minister of Industry, Tourism and Commerce Miguel Sebastian and Chinese Ambassador to Spain Zhu Bangzao attended an inaugural gala dinner here.In a speech, Jiang thanked the Spanish government and authorities for allowing the ICBC to open in Spain and highlighted the importance of the Spanish economy and the close relations between the two countries.Sebastian said Spain welcomes the arrival of the biggest Chinese bank, which would further improve the already good relationship between the two counties.The Madrid branch is to provide a wide range of financial services to 166,000 Chinese nationals living in Spain.ICBC has a total of 386,723 employees and 162 foreign branches throughout the World.